First-line Management of Advanced RCC With IMDC Intermediate-/Poor-Risk Disease

Download this slideset from Martin H. Voss, MD, to learn more about selecting optimal first-line therapy for intermediate-risk/poor-risk patients with advanced RCC.
Martin H. Voss, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.37 MB
Released: February 13, 2020


Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Pfizer and EMD Serono

Supported by a medical education grant from
Exelixis, Inc.
Supported by an independent educational grant from
Merck & Co., Inc.

Related Content

Eunice S. Wang, MD, provides expert insights on a novel chemotherapy/immunotherapy combination for treating ALL in this commentary from Clinical Care Options (CCO)

Eunice S. Wang, MD Released: February 25, 2020

H. Jack West, MD, provides expert insights on treatment options for advanced squamous NSCLC in this commentary from Clinical Care Options (CCO)

H. Jack West, MD Released: February 24, 2020

Commentary on pharmacist’s role in preventing, identifying, and caring for patients experiencing CAR T-cell–associated acute and long-term toxicities.

Shilpa Paul Headshot Shilpa Paul, PharmD, BCOP Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: February 17, 2020 Expiration: February 16, 2021

In this Clinical Care Options (CCO) slideset, Dr. Elizabeth R. Plimack provides insights on managing adverse events and treatment options for advanced RCC after previous therapy

Elizabeth R. Plimack, MD, MS Released: February 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?